ASH 2010 Conference Coverage

Farydak (panobinostat) now FDA-approved for multiple myeloma

Drug is now sanctioned for people who have received at least two prior standard therapies.

ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer

Individuals who've had testicular cancer may be at increased risk for prostate cancer, but the overall risk is low, according to a study.

Urine test could help to guide treatment of bladder cancer

A newly developed urine test could help to guide clinicians in the treatment of bladder cancer patients.

Multiple studies are exploring whether e-cigarettes help smokers quit or continue smoking

Research continues into whether e-cigarettes help smokers quit or actually worsen their habit.

Study identifies reasons for ibrutinib discontinuation in patients with chronic lymphocytic leukemia

About 10% of patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib discontinued their therapy due to disease progression during clinical studies.

New mechanism of acquired resistance to breast cancer drugs discovered

Researchers have discovered that ERBB4 (also known as HER4) is a driver protein in ERBB2-positive tumors that have developed resistance to first- or second-line treatments.

Crucial role of breast cancer tumor suppressor revealed

Cells that contain lower levels of protein profilin 1 in breast tumors have an increased capacity to metastasize and invade other tissues, according to research.

What determines cost-effectiveness of targeted anticancer therapies?

An opinion published in the Journal of Thoracic Disease examines data required to determine the cost effectiveness of cancer treatments.

Post-cancer survival up for Americans, but disparities remain

Study shows biggest improvements in post-cancer survival for people diagnosed between ages 50 and 64.

More than 8 hours of sleep a day associated with increased stroke risk

People who sleep for more than eight hours a day are at increased risk to suffer a stroke, according to a recent study.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs